2022 U.S.-Booked Air Volume: $72M

Consolidated U.S. TMC: CWT

U.S.-booked air spend for pharmaceutical and medical device provider Abbott more than tripled between 2021 and 2022 to $72 million, according to a BTN estimate. However, the 2022 figure is still 31 percent less than the company’s 2019 volume, which came in at $104 million.

The company’s global revenue increased by less than 2 percent year-over-year to $43.7 billion and Abbott added 2,000 new employees to its global workforce, which in 2022 amounted to 115,000 people in more than 160 countries.

While Abbott appears to have eased its strict ‘essential-only’ travel policy that was introduced during the pandemic, two recent acquisitions—of medical device company Cardiovascular Systems and medical tech start-up Bigfoot Biomedical—may see overall travel volumes increase even further into 2023 and beyond. 

In 2022, the company’s travel footprint contributed 2 percent of its Scope 3 carbon emissions.